Virus Diseases Completed Phase 3 Trials for Hepatitis B Vaccine (Recombinant) (DB11627)

Also known as: Virus Disease

IndicationStatusPhase
DBCOND0028162 (Virus Diseases)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01480258Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 4, and 11 to 12 Months (V419-008)Prevention
NCT01553279Immunogenicity and Safety of V419 (PR51) in Combination With MCC in Infants and Toddlers (V419-011)Prevention
NCT01839188Spanish Mixed HEXA/PENTA/HEXA Schedule (V419-010)Prevention
NCT01340937A Study of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-006)Prevention
NCT01337167Safety, Tolerability, and Immunogenicity of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-005)Prevention
NCT02012998Study of the Immunogenicity and Safety of a Challenge Dose of HBVAXPRO in Healthy Children Vaccinated 10 Years Ago With 3 Doses of HEXAVAC or INFANRIX HEXAPrevention
NCT01183611The Safety and Immunogenicity of Recombinant Hepatitis B Vaccines in the Health NeonatesPrevention